News & Events
-
-
Press Announcements
-
-
Sign up to receive FDA Press Releases.
Note: Some links in press announcements are no longer active, but remain for archival purposes. For more information, contact the FDA's Press Office at 301-796-4540.
-
July 2012
- July 18, 2012 - Aprueba la FDA el medicamento Qsymia para bajar de peso
- July 17, 2012 - FDA approves weight-management drug Qsymia
- July 17, 2012 - La FDA aprueba el primer medicamento para reducir el riesgo de infeccion del VIH adquirido sexualmente
- July 17, 2012 - FDA approves new colon-cleansing drug for colonoscopy prep
- July 16, 2012 - FDA approves first drug for reducing the risk of sexually acquired HIV infection
- July 13, 2012 - La FDA alerta a los consumidores sobre peligro de listeria en productos de la compania Mexicali Cheese Corp.
- July 13, 2012 - FDA seeks to halt production, distribution of dietary supplements at NY company
- July 13, 2012 - FDA warns consumers about Listeria threat in Mexicali Cheese Corp. products
- July 12, 2012 - FDA outlines plans to provide earlier feedback on device product submissions
- July 12, 2012 - FDA, UC Davis, Agilent Technologies and CDC to create publicly available food pathogen genome database
- July 10, 2012 - Wisconsin livestock dealer enters into consent decree involving drug residues in cows
- July 09, 2012 - FDA introduces new safety measures for extended-release and long-acting opioid medications
- July 06, 2012 - FDA approves genetic test to help some colon cancer patients, physicians considering Erbitux therapy
- July 05, 2012 - FDA approves first DNA test to help manage CMV infection in organ transplant patients
- July 04, 2012 - FDA prompts companies to remove certain unapproved oxycodone products from market
- July 03, 2012 - La FDA aprueba la primera prueba rapida casera para el VIH de venta libre sin receta medica
- July 03, 2012 - FDA approves first over-the-counter home-use rapid HIV test
- July 03, 2012 - FDA proposes unique device identification system for medical devices
-
June 2012
- June 28, 2012 - FDA approves Myrbetriq for overactive bladder
- June 27, 2012 - La FDA aprueba Belviq para tratar a algunos adultos con sobrepeso u obesos
- June 27, 2012 - FDA approves Belviq to treat some overweight or obese adults
- June 27, 2012 - FDA allows marketing of first test to identify certain bacteria associated with bloodstream infections
- June 25, 2012 - FDA approves first glaucoma stent for use with cataract surgery
- June 15, 2012 - Updated FDA Statement on Compounded Versions of hydroxyprogesterone caproate (the active ingredient in Makena)
- June 15, 2012 - La FDA aprueba una nueva vacuna combinada que protege a los niƱos contra dos enfermedades bacterianas
- June 14, 2012 - FDA urges that oysters, clams, mussels, and some types of scallops from Korea should be removed from the market
- June 14, 2012 - FDA approves new combination vaccine that protects children against two bacterial diseases
- June 08, 2012 - FDA approves Perjeta for type of late-stage breast cancer
- June 06, 2012 - U.S. Marshals seized misbranded drugs in Maine
- June 01, 2012 - La FDA hace una advertencia sobre Reumofan Plus
- June 01, 2012 - FDA issues alert on Reumofan Plus
-
May 2012
- May 29, 2012 - FDA warns consumers about counterfeit version of Teva's Adderall
- May 22, 2012 - FDA-led research team discovers an autoimmune mechanism for serious drug-induced adverse reactions
- May 22, 2012 - U.S. Marshals seize unapproved new drug from Crescendo Therapeutics LLC
- May 17, 2012 - FDA approves generic versions of blood thinner Plavix
- May 15, 2012 - FDA expands use for FilmArray Respiratory Panel
- May 10, 2012 - FDA issues alert on potential dangers of unproven treatment for multiple sclerosis
- May 09, 2012 - FDA proposal aims to help reduce unnecessary radiation exposure for children
- May 03, 2012 - FDA issues final rule on sterility testing of biological products
- May 01, 2012 - FDA permits marketing of a new device for abdominal surgery
- May 01, 2012 - FDA approves new orphan drug to treat a form of Gaucher disease
-
April 2012
- April 27, 2012 - FDA approves new antibacterial treatment for plague
- April 27, 2012 - FDA approves Stendra for erectile dysfunction
- April 27, 2012 - FDA challenges marketing of DMAA products for lack of safety evidence
- April 26, 2012 - FDA approves Votrient for advanced soft tissue sarcoma
- April 26, 2012 - FDA approves Afinitor for non-cancerous kidney tumors caused by rare genetic disease
- April 26, 2012 - FDA Statement on USDA Announcement of Positive BSE Test Result
- April 23, 2012 - FDA strengthens international collaboration to ensure quality, safety of imported products
- April 21, 2012 - Report: FDA strengthens monitoring of post-approval drug safety
- April 20, 2012 - FDA issues draft guidance on nanotechnology
-
-
-
-